Literature DB >> 26902421

Akt phosphorylates myc-associated zinc finger protein (MAZ), releases P-MAZ from the p53 promoter, and activates p53 transcription.

Wei-Ping Lee1, Keng-Hsin Lan2, Chung-Pin Li3, Yee Chao4, Han-Chieh Lin3, Shou-Dong Lee3.   

Abstract

The p53 protein is a cell cycle regulator. When the cell cycle progresses, p53 plays an important role in putting a brake on the G1 phase to prevent unwanted errors during cell division. Akt is a downstream kinase of receptor tyrosine kinase. Upon activation, Akt phorphorylates IKK that then phosphorylates IκB and releases NF-κB, leading to transcriptional activation of Dmp1. Dmp1 is a transcriptional activator of Arf. It has been known that oncogene activation stabilizes p53 through transcriptional activation of Arf, which then binds and inhibits Mdm2. In the current study, we show that myc-associated zinc finger protein (MAZ) is a transcriptional repressor of the p53 promoter. Akt phosphorylates MAZ at Thr385, and the phosphorylated MAZ is released from the p53 promoter, leading to transcriptional activation of p53, a new mechanism that contributes to increased p53 protein pool during oncogene activation.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Akt; Arf; MAZ; Mdm2; Phosphorylation; p53

Mesh:

Substances:

Year:  2016        PMID: 26902421     DOI: 10.1016/j.canlet.2016.02.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Invest       Date:  2018-11-05       Impact factor: 2.176

2.  Over-expression of JAZF1 promotes cardiac microvascular endothelial cell proliferation and angiogenesis via activation of the Akt signaling pathway in rats with myocardial ischemia-reperfusion.

Authors:  Jie Shang; Zhi-Yong Gao; Li-Yan Zhang; Chun-Yu Wang
Journal:  Cell Cycle       Date:  2019-06-18       Impact factor: 4.534

3.  The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.

Authors:  Gargi Maity; Inamul Haque; Arnab Ghosh; Gopal Dhar; Vijayalaxmi Gupta; Sandipto Sarkar; Imaan Azeem; Douglas McGregor; Abhishek Choudhary; Donald R Campbell; Suman Kambhampati; Sushanta K Banerjee; Snigdha Banerjee
Journal:  J Biol Chem       Date:  2018-02-06       Impact factor: 5.157

4.  Identification of the transcription factor MAZ as a regulator of erythropoiesis.

Authors:  Darya Deen; Falk Butter; Deborah E Daniels; Ivan Ferrer-Vicens; Daniel C J Ferguson; Michelle L Holland; Vasiliki Samara; Jacqueline A Sloane-Stanley; Helena Ayyub; Matthias Mann; Jan Frayne; David Garrick; Douglas Vernimmen
Journal:  Blood Adv       Date:  2021-08-10

5.  Overexpression and clinical significance of MYC-associated zinc finger protein in pancreatic carcinoma.

Authors:  Xiaonian Zhu; Wei Luo; Wenjin Liang; Fen Tang; Chunhua Bei; Yuan Ren; Linyuan Qin; Chao Tan; Ying Zhang; Shengkui Tan
Journal:  Onco Targets Ther       Date:  2016-12-12       Impact factor: 4.147

6.  MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transition.

Authors:  Wei Luo; Xiaonian Zhu; Wei Liu; Yuan Ren; Chunhua Bei; Linyuan Qin; Xueyan Miao; Fen Tang; Guifang Tang; Shengkui Tan
Journal:  Oncotarget       Date:  2016-12-27

7.  The transcription factor Maz is essential for normal eye development.

Authors:  Olga Medina-Martinez; Meade Haller; Jill A Rosenfeld; Marisol A O'Neill; Dolores J Lamb; Milan Jamrich
Journal:  Dis Model Mech       Date:  2020-08-18       Impact factor: 5.758

8.  System-wide identification and prioritization of enzyme substrates by thermal analysis.

Authors:  Amir Ata Saei; Christian M Beusch; Pierre Sabatier; Juan Astorga Wells; Hassan Gharibi; Zhaowei Meng; Alexey Chernobrovkin; Sergey Rodin; Katja Näreoja; Ann-Gerd Thorsell; Tobias Karlberg; Qing Cheng; Susanna L Lundström; Massimiliano Gaetani; Ákos Végvári; Elias S J Arnér; Herwig Schüler; Roman A Zubarev
Journal:  Nat Commun       Date:  2021-02-26       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.